ISoOR Insight Team. Genmab Acquires Merus for $8 Billion: The First Organoid-Discovered Clinical Asset Drives the Largest European Oncology Deal of 2025. JOBs [Internet]. 2026 Mar. 2 [cited 2026 Mar. 3];3(1). Available from: https://jobs.isoor.org/index.php/journal/article/view/57